Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors

Microbiology

Volumn 152, Issue 8, 2006, Pages 2247-2255

  Clancy, Cornelius J ^a,b   Nguyen, M Hong ^a,b   Alandoerffer, Ruth ^c   Cheng, Shaoji ^a   Iczkowski, Kenneth ^a,b   Richardson, Malcolm ^c   Graybill, John R ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; MELANIN; PHOSPHOLIPASE; PROTEINASE; VIRULENCE FACTOR;

AIDS PATIENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BRAIN TISSUE; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IN VITRO STUDY; INFECTION SENSITIVITY; INOCULATION; LD 50; MALE; MELANOGENESIS; MENINGOENCEPHALITIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TEMPERATURE DEPENDENCE; UNIVARIATE ANALYSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; LUNG; MALE; MENINGOENCEPHALITIS; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; VIRULENCE; VIRULENCE FACTORS;

CRYPTOCOCCUS NEOFORMANS VAR. GRUBII; FILOBASIDIELLA NEOFORMANS; MURINAE; MUS MUSCULUS;

EID: 33747149174     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.28798-0     Document Type: Article

References (56)

1. Andrade, V. S., Sarubbo, L. A., Fukushima, K., Miyaji, M., Nishimura, K. & de Campos-Takaki, G. M. (2002). Production of extracellular proteases by Mucor circinelloides using D-glucose as carbon source /substrate. Braz J Microbiol 33, 106-110.
2. Barchiesi, F., Cogliati, M., Esposto, M. C., Spreghini, E., Schimizzi, A. M., Wickes, B. L., Scalise, G. & Viviani, M. A. (2005). Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis. J Infect 51, 10-16.
3. Blackstock, R. & Murphy, J. W. (1997). Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans. Infect Immun 65, 4114-4121.
4. Blackstock, R., Buchanan, K. L., Cherniak, R., Mitchell, T. G., Wong, B., Bartiss, A., Jackson, L. & Murphy, J. W. (1999). Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia 147, 1-11.
5. Blasi, E., Barluzzi, R., Mazzolla, R., Mosci, P. & Bistoni, F. (1992). Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization. Infect Immun 60, 3682-3688.
6. Blasi, E., Barluzzi, R., Mazzolla, R., Tancini, B., Saleppico, S., Puliti, L., Pitzurra, M. & Bistoni, F. (1995). Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol 58, 111-116.
7. Casadevall, A. & Perfect, J. R. (1998). Cryptococcus neoformans. Washington, DC: American Society for Microbiology.
8. Casadevall, A., Rosas, A. L. & Nosanchuk, J. D. (2000). Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol 3, 354-358.
9. Chang, Y. C. & Kwon-Chung, J. K. (1994). Complementation of a capsule-deficiency mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14, 4912-4919.
10. Chang, Y. C. & Kwon-Chung, J. K. (1998). Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun 66, 2230-2236.
11. Chang, Y. C. & Kwon-Chung, J. K. (1999). Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol 181, 5636-43.
12. Chang, Y. C., Penoyer, L. A. & Kwon-Chung, K. J. (1996). The second capsule gene of Cryptococcus neoformans, Cap64, is essential for virulence. Infect Immun 64, 1977-1983.
13. Chen, L. C., Blank, E. S. & Casadevall, A. (1996). Extracellular proteinase activity of Cryptococcus neoformans. Clin Diagn Lab Immunol 3, 570-574.
14. Chen, S. C. A., Muller, M., Zhou, J. Z., Wright, L. C. & Sorrell, T. C. (1997). Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis 175, 414-420.
15. Collins, H. L. & Bancroft, G. J. (1991). Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun 59, 3883-3888.
16. Cox, G. M., McDade, H. C., Chen, S. C. A. & 8 other authors (2001). Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39, 166-175.
17. Curtis, J. L., Huffnagle, G. B., Chen, G. H., Warnock, M. L., Gyetko, M. R., McDonald, R. A., Scott, P. J. & Toews, G. B. (1994). Experimental murine pulmonary cryptococcosis: differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab Invest 71, 113-126.
18. Cutler, J. E. (1991). Putative virulence factors of Candida albicans. Annu Rev Microbiol 45, 187-218.
19. Dixon, D. M. & Polak, A. (1986). In vivo and in vitro studies with an atypical, rhinotrophic isolate of Cryptococcus neoformans, Mycopathologia 96, 33-96, 40.
20. Dong, Z. M. & Murphy, J. W. (1995). Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun 63, 2632-2644.
21. Dykstra, M. A., Friedman, L. & Seed, B. (1977). Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect Immun 16, 129-135.
22. Feldmesser, M., Kress, Y. & Casadevall, A. (2001). Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147, 2355-65.
23. Franzot, S. P., Mukherjee, J., Cherniak, R., Chen, L., Hamdan, J. S. & Casadevall, A. (1998). Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66, 89-97.
24. Fries, B. C. & Casadevall, A. (1998). Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis 178, 1761-1766.
25. Fromtling, R. A., Abruzzo, G. K. & Ruiz, A. (1988). Cryptococcus neoformans: a central nervous system isolate from an AIDS patient that is rhinotropic in a normal mouse model. Mycopathologia 102, 72-86.
26. Garcia-Hermoso, D., Dromer, F. & Janbon, G. (2004). Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect Immun 72, 3359-3365.
27. Grosse, G., Mishra, S. K. & Staib, F. (1975). Selective involvement of the brain in experimental murine cryptococcosis. II. Histopathological observations. Zentralbl Bakteriol 230, 518-533.
28. Hasenclever, H. F. & Mitchell, W. O. (1960). Virulence and growth rates of Cryptococcus neoformans in mice. Ann N Y Acad Sci 89, 156-62.
29. Iwata, K., Yamashita, T., Ohsumi, M., Baba, M., Naito, N., Taki, A. & Yamada, N. (1990). Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutants of Cryptococcus neoformans. J Med Vet Mycol 28, 77-90.
30. Jacobson, E. S. & Emery, H. S. (1991). Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J Bacteriol 173, 401-403.
31. Janbon, G. (2004). Cryptococcus neoformans capsule biosynthesis and regulation. FEMS Yeast Res 4, 765-771.
32. Kagaya, K., Yamada, T., Miyakawa, Y., Fukazawa, Y. & Saito, S. (1985). Characterization of pathogenic constituents of Cryptococcus neoformans strains. Microbiol Immunol 29, 517-532.
33. Kozel, T. R. (1995). Virulence factors of Cryptococcus neoformans. Trends Microbiol 3, 295-299.
34. Kwon-Chung, K. J. & Rhodes, J. C. (1986). Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 51, 218-223.
35. Kwon-Chung, K. J., Polacheck, I. & Popkin, T. J. (1982). Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 150, 1414-1421.
36. Kwon-Chung, K. J., Wickes, B. L., Stockman, L., Roberts, G. D., Ellis, D. & Howard, D. H. (1992). Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun 60, 1869-1874.
37. Leighton, T. J., Doi, R. H., Warren, R. A. J. & Kelln, R. A. (1973). The relationship of serine protease activity to RNA polymerase modification and sporulation in Bacillus subtilis. J Mol Biol 76, 103-122.
38. Littman, M. L. & Tsubura, E. (1959). Effect of degree of encapsulation upon virulence of Cryptococcus neoformans. Proc Soc Exp Biol Med 101, 773-776.
39. Macher, A. M., Bennett, E., Gadek, J. E. & Frank, M. M. (1978). Complement depletion in cryptococcal sepsis. J Immunol 120, 1686-1690.
40. Mitchell, T. G. & Perfect, J. R. (1995). Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8, 515-548.
41. National Committee for Clinical Laboratory Standards (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard. Document M-27A. Wayne, PA: National Committee for Clinical Laboratory Standards.
42. Nielsen, K., Cox, G., Wang, P., Toffaletti, D., Perfect, J. R. & Heitman, J. (2003). Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and α isolates. Infect Immun 71, 4831-4841.
43. Nosanchuk, J. D. & Casadevall, A. (2003). Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa. Microbiology 149, 1945-1951.
44. Noverr, M. C., Williamson, P. R., Fajardo, R. S. & Huffnagle, G. B. (2004). CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun 72, 1693-1699.
45. Polacheck, I., Hearing, V. J. & Kwon-Chung, K. J. (1982). Biochemical studies of phenoloxidase and utilization of catechalamines in Cryptococcus neoformans. J Bacteriol 150, 1212-1220.
46. Polak-Wyss, A. (1991). Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses 34, 205-215.
47. Retini, C., Vecchiatelli, A., Monari, C., Tascini, C., Bistoni, F. & Kozel, T. R. (1996). Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect Immun 64, 2897-2903.
48. Rhodes, J. C., Polacheck, I. & Kwon-Chung, K. J. (1982). Phenol-oxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun 36, 1175-1184.
49. Rivera, J., Feldmesser, M., Cammer, M. & Casadevall, A. (1998). Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect Immun 66, 5027-5030.
50. Salas, S. D., Bennett, J. E., Kwon-Chung, K. L., Perfect, J. R. & Williamson, P. R. (1996). Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 184, 377-86.
51. Vanbreuseghem, R. (1967). White mice sensitivity to Cryptococcus neoformans. Production of resistance against a cerebral inoculation. Ann Soc Belg Med Trop 47, 281-294.
52. Van Cutsem, J., Fransen, J., Van Gerven, F. & Janssen, P. A. J. (1986). Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermatropism in guinea pigs. Mykosen 29, 561-575.
53. Vecchiarelli, A., Retini, C., Pietrella, D., Monari, C., Tascini, C., Beccari, T. & Kozel, T. T. (1995). Down-regulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 63, 2919-2923.
54. Vecchiarelli, A., Retini, C., Monari, C., Tascini, C., Bistoni, F. & Kozel, T. R. (1996). Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 64, 2846-2849.
55. Velez, J. D., Allendoerfer, R. R., Luther, M., Rinaldi, M. G. & Graybill, J. R. (1993). Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J Infect Dis 168, 508-510.
56. Williamson, P. R. (1997). Laccase and melanin in the pathogenesis of Cryptococcus neoformans. Front Biosci 2, e99-e107.